Using Robotics In The ATMP Space

By Josh Russell

The use of robotics to manufacture Advanced Therapy and Medicinal Products (ATMP) solves many challenges, including significantly limiting exposure to human-generated contamination. There are steps to mitigate contamination points but with the strong endorsements recently made within the current revision to Annex I encouraging the use of robotics (Section 8.9)¹, eliminating human interventions should be considered seriously.

Learn about the regulatory requirements and GMP recommendations that are trending towards less human interaction and more robotic automation as well as the reasons robotics is the way of the future for the ATMP industry.